Hereditary	O
paraganglioma	B-Cancer
/	O
pheochromocytoma	B-Cancer
and	O
inherited	O
succinate	O
dehydrogenase	O
deficiency	O
.	O

Mitochondrial	B-Cellular_component
complex	O
II	O
,	O
or	O
succinate	O
dehydrogenase	O
,	O
is	O
a	O
key	O
enzymatic	O
complex	O
involved	O
in	O
both	O
the	O
tricarboxylic	O
acid	O
(	O
TCA	O
)	O
cycle	O
and	O
oxidative	O
phosphorylation	O
as	O
part	O
of	O
the	O
mitochondrial	B-Cellular_component
respiratory	O
chain	O
.	O

Germline	O
succinate	O
dehydrogenase	O
subunit	O
A	O
(	O
SDHA	O
)	O
mutations	O
have	O
been	O
reported	O
in	O
a	O
few	O
patients	O
with	O
a	O
classical	O
mitochondrial	B-Cellular_component
neurodegenerative	O
disease	O
.	O

Mutations	O
in	O
the	O
genes	O
encoding	O
the	O
three	O
other	O
succinate	O
dehydrogenase	O
subunits	O
(	O
SDHB	O
,	O
SDHC	O
and	O
SDHD	O
)	O
have	O
been	O
identified	O
in	O
patients	O
affected	O
by	O
familial	O
or	O
'	O
apparently	O
sporadic	O
'	O
paraganglioma	B-Cancer
and	O
/	O
or	O
pheochromocytoma	B-Cancer
,	O
an	O
autosomal	O
inherited	O
cancer	B-Cancer
-	O
susceptibility	O
syndrome	O
.	O

These	O
discoveries	O
have	O
dramatically	O
changed	O
the	O
work	O
-	O
up	O
and	O
genetic	O
counseling	O
of	O
patients	O
and	O
families	O
with	O
paragangliomas	B-Cancer
and	O
/	O
or	O
pheochromocytomas	B-Cancer
.	O

The	O
subsequent	O
identification	O
of	O
germline	O
mutations	O
in	O
the	O
gene	O
encoding	O
fumarase	O
-	O
-	O
another	O
TCA	O
cycle	O
enzyme	O
-	O
-	O
in	O
a	O
new	O
hereditary	O
form	O
of	O
susceptibility	O
to	O
renal	B-Cancer
,	O
uterine	B-Cancer
and	O
cutaneous	B-Cancer
tumors	I-Cancer
has	O
highlighted	O
the	O
potential	O
role	O
of	O
the	O
TCA	O
cycle	O
and	O
,	O
more	O
generally	O
,	O
of	O
the	O
mitochondria	B-Cellular_component
in	O
cancer	B-Cancer
.	O

